CA2228898A1 - An agent for inhibiting carcinogenesis - Google Patents

An agent for inhibiting carcinogenesis Download PDF

Info

Publication number
CA2228898A1
CA2228898A1 CA002228898A CA2228898A CA2228898A1 CA 2228898 A1 CA2228898 A1 CA 2228898A1 CA 002228898 A CA002228898 A CA 002228898A CA 2228898 A CA2228898 A CA 2228898A CA 2228898 A1 CA2228898 A1 CA 2228898A1
Authority
CA
Canada
Prior art keywords
carbostyril
salt
active ingredient
agent
carbostyril skeleton
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002228898A
Other languages
English (en)
French (fr)
Inventor
Toshio Takahashi
Tetsuro Yamane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2228898A1 publication Critical patent/CA2228898A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
CA002228898A 1995-09-06 1996-08-20 An agent for inhibiting carcinogenesis Abandoned CA2228898A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7228889A JPH0971532A (ja) 1995-09-06 1995-09-06 発癌抑制剤
JP7/228889 1995-09-06

Publications (1)

Publication Number Publication Date
CA2228898A1 true CA2228898A1 (en) 1997-03-13

Family

ID=16883451

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002228898A Abandoned CA2228898A1 (en) 1995-09-06 1996-08-20 An agent for inhibiting carcinogenesis

Country Status (7)

Country Link
EP (1) EP0848610A1 (zh)
JP (1) JPH0971532A (zh)
KR (1) KR19990043995A (zh)
CN (1) CN1195987A (zh)
AU (1) AU705751B2 (zh)
CA (1) CA2228898A1 (zh)
WO (1) WO1997009045A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE373502T1 (de) 2003-07-30 2007-10-15 Otsuka Pharma Co Ltd Carbostyril-derivative zur beschleunigten speichelabsonderung
EP3031451B1 (en) 2009-01-26 2018-03-07 Shin-Etsu Chemical Co., Ltd Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
CN103476753B (zh) 2011-02-25 2015-12-09 诺弗米克斯有限公司 新的瑞巴派特复合物和共晶体
KR101395984B1 (ko) * 2011-10-21 2014-05-16 가톨릭대학교 산학협력단 레바미피드를 유효성분으로 포함하는 비만의 예방 또는 치료용 조성물
DE102012218773A1 (de) * 2012-10-15 2014-04-17 Continental Automotive Gmbh Verfahren und Einrichtung zur Messung eines Stroms durch einen Schalter
EP3797773A1 (en) * 2019-09-03 2021-03-31 Square Power Ltd Rebamipide for use in prophylaxis and treatment of cancer
CN110974968B (zh) * 2019-12-11 2021-03-26 中山万远新药研发有限公司 含有喹诺酮类化合物的组合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6010031B2 (ja) * 1983-10-31 1985-03-14 大塚製薬株式会社 カルボスチリル誘導体の製造法
CA2090876A1 (en) * 1991-07-03 1993-01-04 Satoru Nakai Apoptosis regulating composition
TW227558B (zh) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤

Also Published As

Publication number Publication date
JPH0971532A (ja) 1997-03-18
AU705751B2 (en) 1999-06-03
KR19990043995A (ko) 1999-06-25
CN1195987A (zh) 1998-10-14
AU6710096A (en) 1997-03-27
EP0848610A1 (en) 1998-06-24
WO1997009045A1 (en) 1997-03-13

Similar Documents

Publication Publication Date Title
AU676958B2 (en) Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
US20040234593A1 (en) Diphenhydramine tannate compositions and methods of use
KR101257919B1 (ko) 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 경구용 고형 제제 및 이의 제조방법
CA2372538A1 (en) Antitussive/antihistaminic/decongestant compositions
AU705751B2 (en) An agent for inhibiting carcinogenesis
KR100366130B1 (ko) 항과혈당증작용을지닌약제
KR0175345B1 (ko) 장점막 장애 예방 및 치료제
KR100192534B1 (ko) 소마토스타틴 분비증가제와 분비저하 억제제
AU2003217704A1 (en) Diphenhydramine tannate compositions and methods of use
JP2812998B2 (ja) 胃炎治療剤
EP0310259B1 (en) Eperisone as a hypotensive agent
JP2839827B2 (ja) ウレアーゼ阻害剤
JP2002518330A (ja) 処置方法
JP2702284B2 (ja) ソマトスタチン増加用またはソマトスタチン低下抑制用薬剤
JPH01272582A (ja) 消化器系疾患治療剤
JP2898930B2 (ja) 消化器症状改善剤
JPH0665084A (ja) 抗ウイルス剤
WO1998026769A1 (en) Adp-ribosyltransferase inhibitor
JPH045233A (ja) 高脂血症予防及び治療剤
JP2005035995A (ja) イブプロフェン含有経口用組成物
WO1998021194A1 (en) Novel biphenyl dicarboxylic acid derivatives and process for preparing them
JPS58208224A (ja) 抗腫瘍剤
JPH0477729B2 (zh)
JP2011052023A (ja) イブプロフェン含有経口用組成物
JPS61200914A (ja) 抗動脈硬化剤

Legal Events

Date Code Title Description
FZDE Dead